薬剤発見におけるターゲット指向および多様性指向の有機合成
1Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA. sls@slsiris.harvard.edu
Science (New York, N.Y.)
|March 17, 2000
まとめ
このレビューでは,薬物の発見のための合成計画を探索します. 多様性指向合成が,生物学的経路を混乱させる複雑な分子を作り出すことによって,新しい薬物の標的を見つけるのにどのように役立つかを強調しています.
科学分野:
- 薬用化学 薬用化学について
- 合成化学 合成化学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 現代の薬の発見は,しばしば小さな分子をタンパク質の標的としてスクリーニングします.
- リトロシンセティック分析は,焦点を当てたライブラリのターゲット指向の合成の鍵です.
- パスウェイベースのスクリーニングは,事前に定義されたターゲットのない代替アプローチを提供します.
研究 の 目的:
- 多様性指向合成 (DOS) のための合成計画原理の見直し.
- 薬剤発見の進歩におけるDOSの役割を説明するために.
- DOSが新しい治療標的をどのように特定できるかを議論する.
主な方法:
- ターゲット指向合成のためのレトロ合成分析の議論.
- 多様性指向の合成のための前向きな合成分析の探索.
- 構造的に複雑で多様な小分子を生成する原理.
主要な成果:
- DOSは,多様な小分子集合体の効率的な合成を可能にします.
- これらのコレクションは,さまざまな病気に関連する生物学的経路を混乱させることができます.
- DOSは,新しい小分子調節された治療標的の識別を容易にする.
結論:
- 合成計画は,ターゲット指向型と多様性指向型の両方の薬剤発見に不可欠です.
- 多様性指向合成は,新しい薬物標的と治療法を特定するための強力な戦略を提供します.
- 合成経路分析の進化は,将来の薬物発見の取り組みにとって不可欠です.
関連する概念動画
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...